NM_003392.7:c.141-8C>G

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_003392.7(WNT5A):​c.141-8C>G variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000134 in 1,569,866 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00017 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00013 ( 0 hom. )

Consequence

WNT5A
NM_003392.7 splice_region, intron

Scores

2
Splicing: ADA: 0.001647
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: 0.335

Publications

0 publications found
Variant links:
Genes affected
WNT5A (HGNC:12784): (Wnt family member 5A) The WNT gene family consists of structurally related genes which encode secreted signaling proteins. These proteins have been implicated in oncogenesis and in several developmental processes, including regulation of cell fate and patterning during embryogenesis. This gene encodes a member of the WNT family that signals through both the canonical and non-canonical WNT pathways. This protein is a ligand for the seven transmembrane receptor frizzled-5 and the tyrosine kinase orphan receptor 2. This protein plays an essential role in regulating developmental pathways during embryogenesis. This protein may also play a role in oncogenesis. Mutations in this gene are the cause of autosomal dominant Robinow syndrome. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Jan 2012]
WNT5A Gene-Disease associations (from GenCC):
  • autosomal dominant Robinow syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Illumina, Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • autosomal dominant Robinow syndrome
    Inheritance: AD Classification: MODERATE, SUPPORTIVE Submitted by: Orphanet, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 3-55479572-G-C is Benign according to our data. Variant chr3-55479572-G-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 160311.We mark this variant Likely_benign, oryginal submission is: [Conflicting_classifications_of_pathogenicity].
BS2
High AC in GnomAd4 at 26 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
WNT5ANM_003392.7 linkc.141-8C>G splice_region_variant, intron_variant Intron 2 of 4 ENST00000264634.9 NP_003383.4 P41221-1A0A384N611B3KQX9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
WNT5AENST00000264634.9 linkc.141-8C>G splice_region_variant, intron_variant Intron 2 of 4 1 NM_003392.7 ENSP00000264634.4 P41221-1

Frequencies

GnomAD3 genomes
AF:
0.000171
AC:
26
AN:
152148
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000434
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.0000944
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000234
AC:
54
AN:
230506
AF XY:
0.000224
show subpopulations
Gnomad AFR exome
AF:
0.000402
Gnomad AMR exome
AF:
0.000718
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000524
Gnomad FIN exome
AF:
0.0000959
Gnomad NFE exome
AF:
0.000104
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000130
AC:
184
AN:
1417600
Hom.:
0
Cov.:
30
AF XY:
0.000119
AC XY:
83
AN XY:
699200
show subpopulations
African (AFR)
AF:
0.000589
AC:
19
AN:
32266
American (AMR)
AF:
0.000680
AC:
28
AN:
41176
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24676
East Asian (EAS)
AF:
0.000283
AC:
11
AN:
38838
South Asian (SAS)
AF:
0.000151
AC:
12
AN:
79356
European-Finnish (FIN)
AF:
0.000133
AC:
7
AN:
52536
Middle Eastern (MID)
AF:
0.000179
AC:
1
AN:
5580
European-Non Finnish (NFE)
AF:
0.0000931
AC:
101
AN:
1084812
Other (OTH)
AF:
0.0000857
AC:
5
AN:
58360
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
9
19
28
38
47
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000171
AC:
26
AN:
152266
Hom.:
0
Cov.:
33
AF XY:
0.000175
AC XY:
13
AN XY:
74448
show subpopulations
African (AFR)
AF:
0.000433
AC:
18
AN:
41556
American (AMR)
AF:
0.000131
AC:
2
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4828
European-Finnish (FIN)
AF:
0.0000944
AC:
1
AN:
10596
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000588
AC:
4
AN:
68028
Other (OTH)
AF:
0.00
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000114
Hom.:
0
Bravo
AF:
0.000204

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Autosomal dominant Robinow syndrome 1 Uncertain:1
Feb 08, 2013
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Dec 17, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
9.9
DANN
Benign
0.56
PhyloP100
0.34
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.0016
dbscSNV1_RF
Benign
0.11
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs188798140; hg19: chr3-55513600; API